Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor.
Karakaya K, Hanci V, Bektas S, Can M, Ucan HB, Emre AU, Tascilar O, Ozkocak Turan I, Comert M, Irkorucu O, Karadeniz Cakmak G.
World J Gastroenterol. 2009 Oct 28;15(40):5091-6.PMID: 19860004 [PubMed - in process]Related articlesFree article